Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University of Pittsburgh Selects GenomOncology

Published: Wednesday, February 05, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
Company’s GenomAnalytics™ platform and services selected to support research efforts.

GenomOncology has announced that the University of Pittsburgh has selected GenomOncology’s GenomAnalytics™ platform and services to explore and mine the breadth of data that exists in The Cancer Genome Atlas (TCGA).

Cancer is a complex disease of the genome with each tumor having its own set of genetic anomalies. Increased understanding of the genetic changes in cancer cells can lead to precise treatment strategies tailored to the genetic profile of each patient’s cancer.

To further this understanding and advance treatment options, the National Institutes of Health (NIH) has established The Cancer Genome Atlas (TCGA) Data Portal that allows researchers to access and analyze comprehensive, multi-dimensional maps of the key genomic changes in major types and subtypes of cancer.

To date, the TCGA project has focused on more than 20 cancer types and amassed thousands of samples. These samples will be further characterized to include single nucleotide variants, copy number variants, expression level changes, methylation and clinical phenotype data. The University of Pittsburg is one of the largest contributors to TCGA.

The GenomAnalytics platform will be used to investigate and visualize cancer genomic research data as a part of the University’s Personalized Medicine research initiative.

This project will engage the cancer research community and leverage the GenomAnlaytics platform to develop, validate and review scientific hypotheses associated with the unique drivers associated with cancer.

“GenomOncology is honored to work with the University of Pittsburgh on this important initiative.” said Manuel Glynias, President and CEO of GenomOncology. “We are confident that our robust technology platform and onsite support will accelerate the interpretation of the diverse amount of data in TCGA.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pathline Begins Using GenomOncology Clinical Workbench
Company has announced that Pathline has begun using its GO Clinical Workbench for analysis and reporting of NGS tests.
Wednesday, July 13, 2016
GenomOncology Collaborates with Roswell Park Cancer Institute
Collaboration on informatics solution for next-generation sequencing.
Wednesday, February 12, 2014
TriStar Technology Ventures Invests in GenomOncology
Chief Information Officer of MedCare joins board.
Thursday, February 06, 2014
Scientific News
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
NCI Collaborates with Multiple Myeloma Research Foundation
NCI collaborates with MMRF to incorporate genomic and clinical data into NCI Genomic Data Commons database.
Regulatory RNA Essential to DNA Damage Response
Researchers discover a tumour suppressor is stabilized by an RNA molecule, which helps cells respond to DNA damage.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Death-or-Repair Switch Protein Identified
Researchers have identified a protein that plays a key role in the decision process of cell damage repair or cellular suicide.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Wearable Microscope Can Measure Fluorescent Dyes Through Skin
UCLA research could make monitoring disease biomarkers easier and more cost-effective.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!